BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.41% |
| 2 | Financials | 6.99% |
| 3 | Consumer Discretionary | 5.47% |
| 4 | Healthcare | 5.09% |
| 5 | Industrials | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRCL
1901
DELISTED
Stericycle Inc
SRCL
| $736K | ﹤0.01% |
14,449
+12,495
| +639% | +$581K |
|
1902
Genesis Energy
GEL
$1.94B
| $736K | ﹤0.01% |
34,261
+7,568
| +28% | +$164K |
|
1903
Invesco Mortgage Capital
IVR
$804M
| $735K | ﹤0.01% |
4,802
+2,464
| +105% | +$391K |
|
1904
Chewy
CHWY
$9.21B
| $735K | ﹤0.01% |
29,889
+28,335
| +1,823% | +$893K |
|
|
SAGE
1905
DELISTED
Sage Therapeutics
SAGE
| $733K | ﹤0.01% |
5,228
+1,277
| +32% | +$214K |
|
1906
Mine Safety
MSA
$7.28B
| $732K | ﹤0.01% |
6,711
+2,470
| +58% | +$261K |
|
|
WBT
1907
DELISTED
Welbilt, Inc.
WBT
| $732K | ﹤0.01% |
43,389
+38,059
| +714% | +$618K |
|
1908
Insperity
NSP
$2B
| $731K | ﹤0.01% |
7,414
+3,148
| +74% | +$342K |
|
1909
LendingTree
TREE
$459M
| $731K | ﹤0.01% |
2,355
+1,236
| +110% | +$421K |
|
1910
Antero Resources
AR
$11.5B
| $729K | ﹤0.01% |
241,531
+129,541
| +116% | +$528K |
|
1911
Repligen
RGEN
$9.45B
| $727K | ﹤0.01% |
9,484
+4,185
| +79% | +$366K |
|
|
ARNA
1912
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $725K | ﹤0.01% |
15,836
+9,219
| +139% | +$518K |
|
1913
Adeia
ADEA
$3.3B
| $723K | ﹤0.01% |
132,175
+90,576
| +218% | +$485K |
|
1914
Commault Systems
CVLT
$6.09B
| $718K | ﹤0.01% |
16,048
+6,467
| +67% | +$296K |
|
1915
Valley National Bancorp
VLY
$8.28B
| $717K | ﹤0.01% |
65,998
+28,781
| +77% | +$308K |
|
1916
Sprouts Farmers Market
SFM
$7.74B
| $717K | ﹤0.01% |
37,085
-13,361
| -26% | -$245K |
|
|
ELME
1917
Elme Communities
ELME
$144M
| $717K | ﹤0.01% |
26,214
-59,402
| -69% | -$1.6M |
|
1918
CALL
Cleveland-Cliffs
CLF
$6.77B
| $713K | ﹤0.01% |
+987
| New | +$8.89K |
|
1919
NewMarket
NEU
$8.83B
| $712K | ﹤0.01% |
1,509
-10,064
| -87% | -$4.49M |
|
1920
Valvoline
VVV
$4.34B
| $707K | ﹤0.01% |
32,072
+27,788
| +649% | +$596K |
|
|
ALTR
1921
DELISTED
Altair Engineering Inc
ALTR
| $706K | ﹤0.01% |
20,396
+16,640
| +443% | +$620K |
|
1922
Hancock Whitney
HWC
$6.4B
| $701K | ﹤0.01% |
18,296
+8,428
| +85% | +$320K |
|
1923
Rio Tinto
RIO
$156B
| $701K | ﹤0.01% |
13,450
+12,650
| +1,581% | +$686K |
|
|
EMBJ
1924
Embraer S.A. ADS
EMBJ
$13.3B
| $696K | ﹤0.01% |
40,376
-782
| -2% | -$14.9K |
|
|
ZEN
1925
DELISTED
ZENDESK INC
ZEN
| $696K | ﹤0.01% |
9,550
-4,084
| -30% | -$336K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.6% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.